Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer

By Ingle J.N.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 3, 1997-05 ,pp. : 193-200

Springer Publishing Company

Access to resources Recommend Favorite

Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin

By Venturino A.  

Breast Cancer Research and Treatment, Vol. 60, Iss. 3, 2000-04 ,pp. : 195-200

Springer Publishing Company

Access to resources Recommend Favorite

Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients

By Bascioni R.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 3, 1997-09 ,pp. : 205-210

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of 5-Fluorouracil, Leucovorin and Cisplatin (FLP) for Metastatic Gastric Cancer

By Ychou M.   Astre C.   Rouanet P.   Fabre J.M.   Saint-Aubert B.   Domergue J.   Ribard D.   Ciurana A.J.   Janbon C.   Pujol H.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 1933-1937

Elsevier

Access to resources Recommend Favorite

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

By Maindrault-Goebel F.   Louvet C.   Andre T.   Carola E.   Lotz J.P.   Molitor J.L.   Garcia M.L.   Gilles-Amar V.   Izrael V.   Krulik M.   de Gramont A.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1338-1342

Elsevier

Access to resources Recommend Favorite